The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf012 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Oncologist, 2025. Verfasst von Carmine Valenza und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy. Hauptthemen laut MEDLINE: Phyllodes Tumor, Breast Neoplasms, Mediator Complex. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In patients with phyllodes tumors of the breast, the presence of mediator of RNA polymerase II transcription subunit 12 homolog mutations (MED12m) and a history of previous fibroadenoma may predict better outcomes. To aid in the prognostication of malignant phyllodes tumors of the breast (B-MPT), we assessed the prognostic value of fibroadenoma-like areas (supposed to have stemmed from a pre-existing fibroadenoma) and MED12m, in patients with resected primary B-MPTs.
Methods
We conducted a single-center, retrospective, cohort study including all consecutive patients aged ≥18 years old, with non-metastatic B-MPT, who underwent surgery from January 2000 to December 2021. The endpoints were the cumulative incidences of all recurrences, according to the presence of fibroadenoma-like areas, reviewed by 3 reference pathologists. A nested, case-control genomic analysis was performed to evaluate the association between MED12m, the presence of fibroadenoma-like areas, and cancer recurrences.
Results
Eight-nine patients were included, with 47% of tumors exhibiting Fibroadenoma-Like Areas (FLA+). These areas were not significantly associated with local recurrence (5-year cumulative incidence in FLA+ vs FLA-: 13.0, 95%CI [4.6-25.9] vs 23.6, 95%CI [11.9-37.5]; P = .14) or distant recurrence (5-year cumulative incidence in FLA+ vs FLA-: 12.5, 95%CI [4.5-25.0] vs 8.9, 95%CI [2.8-19.5], P = .61), at a median follow-up of 6.7 years. MED12m was not associated with distant recurrences or the presence of fibroadenoma-like areas.
Conclusions
Half of B-MPTs are characterized by the presence of fibroadenoma-like areas. This pathologic feature is not significantly associated with lower distant and local recurrences nor with the presence of MED12 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan 20141, Italy.
- Department of Oncology and Hemato-Oncology, University of Milan, Milan 20122, Italy.
- Division of Pathology, European Institute of Oncology, IRCCS, Milan 20141, Italy.
- Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan 20141, Italy.
- Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo 24125, Italy.
- Division of Melanoma, Soft Tissue Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan 20141, Italy.
ORCID-Profile: Dario Trapani, Giuseppe Curigliano
Zitieren
APA
Valenza, C., Trapani, D., Porta, F. M., Olmeda, E., Gaeta, A., Boscolo Bielo, L., Conversano, F., De Pas, T. M., Castellano, G., Santoro, C., Battaiotto, E., Mane, E., Coppola, S., Conforti, F., Mattar, D., Gandini, S., Veronesi, P., Guerini Rocco, E., Pennacchioli, E., & Curigliano, G. (2025). The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis. The Oncologist. https://doi.org/10.1093/oncolo/oyaf012
Vancouver
Valenza C, Trapani D, Porta FM, Olmeda E, Gaeta A, Boscolo Bielo L, et al. The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis. The Oncologist. 2025. doi:10.1093/oncolo/oyaf012
BibTeX
@article{Valenza2025,
author = {Valenza, Carmine and Trapani, Dario and Porta, Francesca Maria and Olmeda, Edoardo and Gaeta, Aurora and Boscolo Bielo, Luca and Conversano, Federica and De Pas, Tommaso Martino and Castellano, Grazia and Santoro, Celeste and Battaiotto, Elena and Mane, Eltjona and Coppola, Sara and Conforti, Fabio and Mattar, Denise and Gandini, Sara and Veronesi, Paolo and Guerini Rocco, Elena and Pennacchioli, Elisabetta and Curigliano, Giuseppe},
title = {The pathologic and genomic evolution of primary malignant phyllodes tumors of the breast: retrospective cohort study and case-control genomic analysis},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf012}
}
EUVIMED